Neoadjuvant Endocrine Therapy in Breast Cancer Up-Regulates the Cytotoxic Drug Pump ABCG2 /BCRP, and May Lead to Resistance to Subsequent Chemotherapy
Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2018.07.002
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Elsevier BV